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TTLE BONE DISEASE 
i TTing- uterine 
fibroids 
used to mean giving 
up a lot more than 
a night in the hospital 
hile uterine fibroid rumors are benign, their impact on a 
woman's life is anything but—often resulting in a hysterec- 
tomy or other invasive surgeries. But today, many women 
are choosing procedures that spare the uterus. 
Uterine Fibroid Embolization (UFE) is a minimally invasive 
procedure performed by an interventional radiologist. By blocking the 
blood flow to the tumors and causing them to shrink, the procedure is 
approximately 90% successful at alleviating the heavy bleeding and painful 
periods often associated with fibroids. 
As compared with other fibroid treatments, UFE 
usually requires only an overnight stay in the hospital 
and has a quicker recovery time. 
Established in 1998, the Washington University 
Comprehensive Fibroid Center has accumulated the 
largest experience with UFE treatment in St. Louis. Most 
major insurance carriers, Medicare, and Medicaid recog- 
nize UFE as an accepted alternative treatment for fibroids. 
For more information about UFE or other minimally 
invasive interventional radiology procedures offered 
at Washington University Medical Center, 
call (314) 362-2353. 
W Washington 
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Physicians 
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AN INTERVIEW WITH SIMON POWELL, MD, PHD 
Simon Powell, an internationally known cancer 
physician-scientist, was named chairman of the 
Department of Radiation Oncology in July 2004. 
Now, nearly a year later, he discusses the challenges 
of leading the four-year-old department and outlines 
his goals for patient care, research, and education. 
IF THE SHOE DOESN'T FIT. 
Many of the 18 million Americans with diabetes 
suffer from foot problems, including a condition 
in which severely diminished sensation in the 
feet causes ulcers and can lead to amputation. 
Researchers from the Institute's Electronic 
Radiology Laboratory and from the School of 
Medicine's Program of Physical Therapy are using 
spiral CT to develop a three-dimensional model 
that they hope will revolutionize orthotic design. 
OSTEOPOROSIS: THE BRITTLE BONE DISEASE 
At around 30 years of age, men and women slowly 
begin to lose bone mass. And in the five years 
following the onset of menopause, bone density 
in women deteriorates rapidly. Nuclear medicine 
physicians at Mallinckrodt Institute are using 
Dual-Energy X-ray Absorptiometry to diagnose 
bone loss, enabling patients to begin treatment 
that will fight the advance of osteoporosis. 
Visit the MIR web site at 
w.mir.wustl.edu 
ON THE COVER According to the National Institutes of Health, osteoporosis is a health threat for 44 million Ameri- 
cans, 68% of whom are women. It is estimated that one out of two women over the age of 50 will have an osteo- 
porosis-related fracture in her lifetime. The disease can develop at any stage in a person's life, but osteoporosis can 
be prevented and treated. Illustration by Matt Kindt. 
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They are all 
winners... 
Since 1989 the radiation 
oncology residents annually 
select the Teacher of the 
Year recipient by nominating 
and voting for the faculty 
member who makes a signifi- 
cant contribution to radiation 
oncology resident education 
during the academic year. 
The award is presented each 
year in December. 
This year the residents 
broke from tradition. "The 
residents did not select a 
teacher of the year for 2004," 
says Parag Parikh, MD, 
radiation oncology assistant 
chief resident. "Many of the 
attendings [physicians on 
faculty] this year went 
above and beyond in their 
teaching responsibilities, 
from increased participation 
in the Patient Management 
Conference to their support 
of our new Management and 
Techniques sessions. We 
[the residents] did not think 
it was fair—nor could we 
come to a conclusion—to 
name one attending as the 
'Teacher of the Year.'" 
Past award recipients 
• Susan Shapiro, MD—1989 
• Carlos Perez, MD—1990, 
2003 
• Perry Grigsby, MD, 
MBA—1991, 1995, 2000 
• JeffMichalski, MD—1992 
• Russell Gerber, MS—1993 
• Mary Graham, MD—1994 
• James Purdy, PhD—1996 
• Marie Taylor, MD—1997 
• David Gius, MD, PhD— 
1998 
• Jeffrey Bradley, MD— 
1999 
• Joseph Simpson, MD, 
PhD—2001 




Yasha Kadkhodayan, a 
fourth-year medical student, 
received the 2004-2005 
Hugh M. Wilson Award for 
Meritorious Work in Radiol- 
ogy. The award is presented 
in honor of Mallinckrodt 
Institute's second director, 
who was an advocate of the 
advancement of education. 
Kadkhodayan earned 
an undergraduate degree, 
majoring in bioengineering, 
from the University of Illinois 
at Chicago (UIC). During his 
four years at UIC, Kadkho- 
dayan participated in research 
projects involving the use of 
phase-contrast magnetic reso- 
nance imaging (MRI) to study 
the craniospinal system. 
During his first year at 
Washington University in 
St. Louis School of Medicine 
(WUSM), Kadkhodayan 
voiced his interest in neuro- 
radiology and radiology to 
Colin Derdeyn, MD, associ- 
ate professor of radiology 
and of neurology and neuro- 
logical surgery. With 
Derdeyn's sponsorship, 
Kadkhodayan received 
an American Academy of 
Neurology summer research 
fellowship and worked 
closely with doctors 
Derdeyn, Christopher 
Moran, and DeWitte Cross— 




on several projects, includ- 
ing MRI measurements of 
brain temperature in stroke, 
and performed an exhaustive 
chart review study. His 
efforts resulted in a paper on 
"Yield of conventional 
angiography for primary 
angiitis of the central 
nervous system" being pub- 
lished in Radiology and a 
second paper—"Procedural 
complications of a carotid 
angioplasty and stenting 
without cerebral protection 
devices"—published in 
Neurosurgical Focus. Two 
additional papers have been 
accepted for publication by 
the American Journal of 
Neuroradiology. 
Kadkhodayan will begin 
his first year of diagnostic 
radiology residency at 
Mallinckrodt Institute in 
July 2006, after completing a 
preliminary training year in 
medicine at Barnes-Jewish 
Hospital. 
WUSM ranks 
third in nation 
According to the April 
2005 U.S. News & World 
Report survey, Washington 
University in St. Louis 
School of Medicine (WUSM) 
ranked third in the nation 
among research intensive 
medical schools. Among the 
top 10 schools, Harvard Uni- 
versity took first-place hon- 
ors and Johns Hopkins 
University placed second; 
following WUSM were the 
University of Pennsylvania, 
University of California-San 
Francisco, Duke University, 
University of Washington, 
Stanford University, Univer- 
sity of Michigan, and Colum- 
bia University. 
U.S. News & World 
Report initiated the profes- 
sional and graduate school 
rankings in 1987. WUSM 
annually has placed in the 
top 10 schools and, since 
1998, has ranked first in 
student selectivity. For the 
eighth consecutive year, 
WUSM's students have had 
the highest undergraduate 
grade-point averages and 
the highest scores on 
medical school entrance 
examinations. 
Listings for all Washing- 
ton University in St. Louis 
schools, departments, and 
programs are available at 
news-info.wustl.edu/rankings. 




Tom Miller, MD, PhD, 
professor of radiology and 
of biomedical engineering, 
has been elected to a one- 
year term as chairman of the 
American Board of Nuclear 
Medicine (ABNM). Founded 
in 1971, the ABNM was 
established to set education 
standards and to evaluate 
the competence of physi- 
cians providing nuclear 
medicine services in the 
United States. ABNM's 
responsibilities include set- 
ting the requirements for 
certification, conducting 
examinations leading to 
certification in nuclear 
medicine, and issuing 
certificates to those 
physicians who fulfill the 
requirements. From 1972 
to 2004, the ABNM has 
certified 4,869 physicians. 
The 12 Board members 
serve three-year terms; 
officers, a one-year term. 
Henry Royal, MD, 
professor of radiology, is 
the ABNM executive direc- 
tor, and Barry Siegel, MD, 
professor of radiology and 
of medicine, is designated as 





On July 1, 18 physicians 
will begin their first year of 
training in diagnostic radiol- 
ogy. These promising 
trainees come to MIR from 
excellent medical schools: 
• Weill Medical College 
of Cornell University 
• Duke University School 
of Medicine 
• Emory University 
School of Medicine 
• Georgetown University 
School of Medicine 
• I.M. Sechenov Moscow 
Medical Academy 
• Indiana University 
School of Medicine 
• Johns Hopkins University 
School of Medicine 
• Tulane University 
School of Medicine 
• David Geffen School of 
Medicine at the University 
of California, Los Angeles 
• University of Missouri- 
Columbia School of 
Medicine 
• University of Pennsylvania 
School of Medicine 
• Washington University 
in St. Louis School of 
Medicine. 
David Johnson, MD, ASCO president, presented the award to Farria (left) 
and Darlene Bird, clinical research coordinator, at the 2005 ASCO Annual 




On behalf of the Breast 
Imaging Team at Siteman 
Cancer Center (SCC), Dione 
Farria, MD, received the 
Clinical Trials Participation 
Award from The American 
Society of Clinical Oncology 
(ASCO), one of the world's 
leading organizations repre- 
senting physicians who treat 
cancer. The award was 
created in 2003 to publicly 
honor practices and institu- 
tions that actively participate 
in clinical trials research. 
The award program is 
supported by a grant from 
the Coalition for National 
Cancer Cooperative Groups. 
Farria and Katherine 
Jahnige Matthews, MD, 
assistant professor of obstet- 
rics and gynecology, are 
directors of the SCC Pro- 
gram for the Elimination of 
Cancer Disparities (PECaD). 
The SCC program works 
within existing community 
networks to build trusting 
relationships that ultimately 
help to attract patients to 
clinical trials. PECaD also 
provides the St. Louis-area 
community with health 
information and assistance 
in obtaining patient care. As 
the largest of the multidisci- 
plinary clinical centers in the 
Center for Advanced Medi- 
cine, the SCC is a collabora- 
tive effort of Washington 
University in St. Louis 
School of Medicine and 
Barnes-Jewish Hospital. 
As principal investiga- 
tor, Farria received a Com- 
munity Networks Program 
grant of $1.2 million from the 
National Cancer Institute to 
support the PECaD work. 
Matthews is coinvestigator 
for the five-year grant. 







In a 2005 report on the 
nation's nanotechnology 
research efforts, the Presi- 
dent's Council of Advisors 
on Science and Technology 
determined that the United 
States is the acknowledged 
international leader in nan- 
otechnology research and 
development and recom- 
mended that further steps be 
taken to facilitate technology 
transfer from the laboratory 
to the marketplace. The 
Council also called for 
continued research on 
environmental, health, and 
other societal issues and for 
support for education and 
workforce preparation. 
Nanotechnology— 
working with matter that 
is one billionth of a meter— 
has been hailed as the "new 
industrial revolution." 
Researchers across the 
nation are attempting to 
devise methods for imaging 
and constructing at the 
atomic and molecular level. 
As part of a new nano- 
technology initiative, The 
National Heart, Lung, and 
Blood Institute (NHLBI) of 
the National Institutes of 
Health selected Washington 
University in St. Louis 
(WUSTL)asoneoffour 
universities designated as a 
Program of Excellence in 
Nanotechnology (PEN). The 
WUSTL program will serve 
as the administrative center 
for the national project. 
The NHLBI awarded a 
five-year, $12.5 million grant 
to Principal Investigator 
Karen Wooley, PhD, profes- 
CCIR progress 
The first step in the construction of the Center for Clinical Imaging Research (CCIR) was to completely gut the 9,000 square- 
foot area on 10 West Pavilion. The CCIR is part of the Institute's strategy for providing advanced imaging resources and 
support for clinical investigators whose biomedical research will facilitate better diagnosis and management of disease. Mark 
Mintun, MD, professor of radiology, is the CCIR director. 
sor of chemistry, and 
Co-principal Investigator 
Michael Welch, PhD, profes- 
sor of radiology, of chem- 
istry, and of molecular 
biology and pharmacology, 
to focus on the "develop- 
ment of nanoscale agents 
that can be assembled, 
labeled, targeted, filled, 
and activated for eventual 
diagnosis and treatment of 
various diseases relevant to 
NHLBI." Welch's expertise 
in the area of rapid synthesis 
of positron-labeled organic 
chemicals—a vital compo- 
nent in the development of 
positron emission tomogra- 
phy at the Institute in the 
1970s—and his research 
on developing image 
enhancements ultimately 
used in clinical radiology 
techniques and procedures 
will play an important role 
in the PEN project. 
Among the 13 WUSTL 
and School of Medicine PEN 
collaborators are Mallinck- 
rodt Institute's Robert 
Gropler, MD, professor of 
radiology, of medicine, and 
of biomedical engineering; 
Pamela Woodard, MD, 
assistant professor of radiol- 
ogy; Daniel Schuster, MD, 
professor of medicine and 
of radiology. Also involved 
are Carolyn Anderson, PhD, 
associate professor of radiol- 
ogy; Robert Mach, PhD, 
professor of radiology; and 
Jason Lewis, PhD, assistant 
professor of radiology. 
More information on 
the PEN project is available 
on the Internet: NHLBI 
(www.nhlbi.nih.gov) or the 
National Nanotechnology 
Initiative (www.nano.gov/). 
MALUNCKRODT INSTITl '77? OF RADIOLOGY 
An Interview 
with Simon Powell, MD, PhD 
In July 2001, Washington 
University School of Medicine (WUSM) 
established the Department of Radiation 
Oncology from what had been known 
as Mallinckrodt Institute's Division of 
Radiation Oncology. Carlos Perez, MD, 
was appointed interim chairman of the 
new department. After an extensive 
national search by WUSM, Simon Powell, 
MD, PhD, was named professor and 
department chairman in July 2004. 
Here, Dr. Powell discusses 
the challenges and goals for the 
department, particularly in the areas 
of technology, patient care, research, 
and education. 
Focal Spot (FS): You came to 
Washington University Medical 
Center from one of the United 
States' healthcare giants—Harvard 
University and Massachusetts 
General Hospital. What were your 
first impressions of Washington 
University Medical Center? 
Dr. Powell (SP): I was impressed 
by the size and range of activities 
in the Medical Center. My first and 
continuing impressions are that 
there are no limits to what can be 
achieved on this site. 
FS: The Department of Radiation 
Oncology encompasses patient 
care, research, and teaching. What 
are the department's strengths in 
handling such a wide range of 
responsibilities? 
SP: Excellent faculty. They 
drive everything. The faculty I 
inherited was already in good 
shape, although I am devoting a 
significant amount of time to new 
faculty recruitment. 
FS: The radiation oncology 
residency training program is 
well-known nationally. How 
important do you think the 
department's mentoring program, 
research facilities, and affiliations 
with BJC HealthCare are in 







SP: I think prospective residents 
are looking for a well-balanced 
program. Good clinical experience, 
opportunities for research, and 
excellence in mentoring. The opera- 
tion of our department's program in 
a large general medical center 
provides a realistic balance of the 
role of radiation oncology in the 
context of other medical specialties. 
FS: Whether it can be attributed to 
the Internet, the media, or just to 
curiosity, patients are better 
informed regarding healthcare 
options. They expect to be actively 
involved in the health-related deci- 
sion-making process and are proac- 
tive in seeking cancer care. How is 
this physician-patient partnership 
addressed in the department? 
SP: We spend a lot of time with our 
patients at their first consultation. 
We gather as much essential infor- 
mation as possible prior to seeing 
the patient, so we can focus our time 
on answering their questions. Since 
radiation oncology often comes later 
in the medical process, our consulta- 
tions provide an opportunity for 
patients to get a deeper perspective 
of their treatment options. 
FS: What effect do you think rising 
technology costs and reduced 
Medicare and managed care 
reimbursements are having on 
cancer care? 
SP: They clearly have an impact, but 
both are changing. New technology 
often starts with one level of CPT 
[Current Procedural Technology] 
code payment but, in time, the CMS- 
based [Centers for Medicare and 
Medicaid Services-based] Medicare 
payments tend to go down. What we 
must avoid is that payment policies 
start to dictate practice. 
lilt ulty. // 
FS: In 1971, the United States gov- 
ernment hailed the National Cancer 
Act as a "national battle plan to 
eradicate cancer in our lifetime." 
Nationally, what advancements do 
you think are bringing us closer to 
that cure? 
SP: The major area of development 
is the recognition that site-specific 
cancers are a mixture of diseases, 
with different characteristics. 
These characteristics of the tumors 
can tell us how to treat individual 
tumors optimally. This will 
increasingly become a combination 
of a biological agent with a conven- 
tional cytotoxic agent, such as 
radiation and chemotherapy. 
FS: In the past decade, there has 
been tremendous technological 
growth in radiation therapy, espe- 
cially in computer-based systems. 
What advances do you foresee in the 
next decade? What role will WUSM 
radiation oncology play in the 
development of new technology? 
SP: The last decade was character- 
ized by the development of what is 
called "intensity modulated" radia- 
tion therapy. This allowed the 
delivery of radiation to all types of 
complicated tumor shapes. The 
next decade will be characterized 
by the introduction of image guid- 
ance. This new technology allows 
greater precision in the delivery of 
treatment and can allow what is 
called "adaptive therapy." Adaptive 
therapy takes into account the 
changes in the size and shape of 
the tumor during the course of 
treatment. By acquiring two new 
treatment machines that offer 
full-image guidance, WUSM hopes 
to play a key role in developing 
the new applications of image- 
guidance therapy. 
I 
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• •• there are no limits..." 
FS: The department has a broad- 
based research program. Do you 
have plans for research expansion? 
SPlYes. We plan to expand our 
research mission in all divisions of 
the department. I have created a new 
Division of Bioinformatics and 
Outcomes Research. Computer- 
based data analysis is becoming 
increasingly important in oncology 
research. The biggest change will be 
in our biology division, where we are 
developing a program in DNA repair 
and genome stability for the Siteman 
Cancer Center. 
FS: What effect will the increased 
competition for research dollars 
have on the department's research 
programs? 
SP: The competition will apply 
more pressure on our faculty— 
and every research group in the 
country—to develop competitive 
research programs. We will have 
to focus our research on areas of 
clear strength and work on our 
grant submissions to make them 
as effective as possible. 
FS: How important is interdisci- 
plinary collaboration to the 
advancement of science and 
medicine? Does radiation oncology 
have interdisciplinary programs 
in place? Future 
plans? 
SP: The DNA repair program will 
be interdisciplinary, like all Siteman 
Cancer Center programs. We also 
plan an interdivisional group under 
the umbrella of the Center for 
Molecular Targeted Radiotherapy. 
This center will integrate biology, 
physics, and clinical work with a 
strong translational initiative. We 
also see the interdisciplinary disease 
focus groups having a much stronger 
presence in the years to come. 
FS: The current focus at most med- 
ical centers is on cost control. How 
can the department continue to drive 
progress while reducing cost? 
SP: We have just completed a thor- 
ough review of our faculty and staff 
positions. We cannot afford to keep 
positions that are no longer needed in 
the new formula for the department. 
Although it is never a favorite job to 
eliminate positions, we think the 
department will emerge stronger as 
a consequence. It will allow new 
initiatives at a time of being cost- 
conscious. 
FS: What are your overall long- 
range goals for the Department 
of Radiation Oncology? 
SP: Our long-range goals are to 
develop intradepartmental transla- 
tional programs arising out of strong 
basic science research. In academic 
medicine, the goal is always to push 
the envelope of treatment. In concert 
with strong Siteman Cancer Center 
programs, this new vision for our 
department can flourish. 
FS: Short-range goals? 
SP: The short-range goals 
are to complete our new 
faculty recruitments 
successfully. As I stated 
earlier, faculty is the key 
to our strength in our aca- 
demic mission. We have 
reorganized our adminis- 
tration to allow greater 
efficiency in supporting 
our new initiatives. 
FS: Anything you would 
like to add? 
SP:Yes. My first seven 
months have been very 
busy but very productive. 
All of the faculty and staff 
I have met have been 
extraordinarily supportive 
in helping this new 
department on the road to 
becoming the finest radia- 
tion oncology department 
in the country. 
FS: Thank you, Doctor 
Powell. EH 
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Fit 
A typically pleasant St. Louis spring 
beckons walkers, joggers, golfers, 
skaters, and bikers to the outdoors. 
But for millions of people with diabetes 
and peripheral neuropathy, a simple stroll 
poses a hidden threat to future mobility. 
Many of the 18 million Americans 
with diabetes suffer from severe foot 
problems, including neuropathy, bone 
and joint deformities, and ulcers. 
Diabetes damages the communication 
network from the brain and spinal cord to 
the extremities—a condition called diabetic 
peripheral neuropathy (DPN). Patients with 
DPN lose sensation in their feet, and any 
minor cut or blister can lead to a serious foot 
ulcer. DPN also causes weakness in certain 
muscles of the foot; the anatomy of the foot 
actually changes as people unknowingly 
adapt their gait to compensate for the loss 
of muscle. Pressure builds on the metatarsal 
heads (the joints under the ball of the foot), 
causing internal or external ulcers. 
Successful treatment and 
prevention of foot ulcers 
requires specially fitted shoes 
and orthotic devices, such as a 
special shoe insert, that redis- 
tribute pressure away from 
parts of the foot that are ulcer- 
ated or may develop ulcers. 
However, even with orthotic 
devices, ulcers recur in more 
than 50 percent of cases. 
Unless they diligently examine 
their feet for subtle changes in 
skin appearance, patients may 
not realize that an orthotic 
device is not functioning 
properly until an ulcer reap- 
pears. A severely infected foot 
may have to be amputated. 
More than 80,000 lower-limb 
amputations are performed on 
diabetic patients in the United 
States every year, at a cost 
of $30,000 to $60,000 per 
operation. According to the 
American Diabetes Associa- 
tion, up to 85 percent of these 
amputations could be pre- 
vented with better diagnosis 
and treatment. 
Mallinckrodt Institute of 
Radiology (MIR) scientists are 
collaborating with a team of 
researchers and technicians, 
looking at new ways to assess 
severe foot problems in diabetic 
patients and to provide the best 
orthotic device for any patient as 
quickly as possible. Kirk Smith, 
an MIR senior research engineer, 
explains, "We are using spiral CT 
[computed tomography] technol- 
ogy to portray the structure of a 
diabetic patient's foot in a way 
that has not been done before. 
Our goal is to help clinicians 
match the best orthotic device 
with a patient's unique foot 
structure and prevent the all-too- 
common recurrence of ulcers." 
Kirk Smith 
A remarkable interdisciplinary 
collaboration has advanced 
research into the causes and treat- 
ment of a diabetic patient's foot 
problems from the discovery phase 
to potential practical application. 
The latest in a series of research 
studies by the team will be pub- 
lished soon in the Journal of 
Biomedical Engineering. The 
paper will describe a working 
three-dimensional model of foot 
problems caused by diabetes. The 
team hopes the research will revo- 
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Shoe Doesn't Fit 
THE   RESEARCH  TEAM 
Washington University 
Department of Radiology 
(Mallinckrodt Institute} 
• Kyongtae Bae, MD, PhD, associ- 
ate professor of radiology 
• James Blaine, DSc, emeritus pro- 
fessor of radiology 
• Paul Commean, BEE, senior 
research engineer 
• Tom Pilgram, PhD, instructor in 
radiology 
• Fred Prior, PhD, research associ- 
ate professor of radiology 
• Kirk Smith, AAS, senior research 
engineer 
lutionize orthotic design—a field in 
which methods have changed little 
in the 30 years since the advent of 
modern orthotics. 
Michael Mueller, associate 
professor of physical therapy, 
emphasizes the advantages of the 
interdisciplinary research: "This 
team has the expertise to evaluate 
all the complex variables that can 
affect the development of foot 
problems in the diabetic patient, 
such as the physiological structure 
of the foot, the effect of gait on 
pressure points, and the material 
properties of the orthotic devices. 
And we are using advanced compu- 
tational modeling techniques to 
test the reliability of our predic- 
tions. Orthotic design today is 
more art than science, and good 
design is largely a function of the 
experience of the pedorthist. We're 
trying to bring science into the pic- 
ture to improve orthotic design." 
This is not the first collabora- 
tion between physical therapy 
clinicians and MIR researchers. 
Michael Mueller, PhD 
Program in Physical Therapy 
• Mary Hastings, DPT, instructor in 
physical therapy 
• Joseph Klaesner, PhD, research 
assistant professor of physical 
therapy 
• Donovan Lott, MS, PT, predoc- 
toral trainee 
• Michael Mueller, PhD , associate 
professor of physical therapy 
• Dequan Zou, DSc, research assis- 
tant professor of physical therapy 
Department of Orthopaedic Surgery 
• Jeffrey Johnson, MD, associate 
professor of orthopaedic surgery 
Matthew Silva, MD, associate pro- 
fessor of orthopaedic surgery 
In the late 1990s, Smith and a 
research team developed better- 
fitting prosthetic devices for 
patients who had an amputated 
limb. As CT technology advanced, 
and lower-dose scans became the 
norm, Mueller asked Smith if spiral 
CT could be used to develop a 
better understanding of the 
underlying causes of foot problems 
caused by diabetes. The team 
embarked on a series of studies 
that would give a complete picture 
of foot structure and peak plantar 
pressures, the measure of pressure 
on the foot that eventually causes 
ulcers to form. 
Before CT, evaluating the 
structure of the foot was like 
putting together a jigsaw puzzle— 
with only half the pieces. X rays 
could display bones but only in a 
single plane. Viewed in profile, only 
the first or fifth metatarsal could be 
examined in detail, as the interior 
views were obscured. Ultrasonog- 
raphy lent information about soft 
tissue but not in connection with 
bone detail. Research involving 
Department of Mechanical Engineering 
and Aerospace 
• Ricardo Actis, DSc, adjunct p 
fessor of mechanical engineer 
• Barna Szabo, PhD, professor 
of mechanical engineering and 
aerospace 
Other collaborators 
• Liliana Ventura, Engineering Soft- 
ware Research & Development, 
Inc. 
• pedorthist consultants 
10 
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MIR scientists and Mueller has 
demonstrated spiral CT's many 
advantages over these earlier 
methods. With CT, bone structure 
and soft tissue can be evaluated 
together and can use the same 
scale, and three-dimensional views 
allow greater detail examination. 
The team was able to take accurate 
measurements of such key attrib- 
utes as toe angle for each 
metatarsal, severity of "hammer 
toe" deformity, bone density, and 
hallux valgus angle. 
The team also used CT to 
understand how soft tissue is 
affected by pressure from standing 
and walking. Using a specially 
designed seat, a plate to provide 
pressure, and special sensors 
taped to a person's foot, the team 
simulated standing, push-off, and 
walking pressures on the foot. By 
recording soft tissue thickness, 
peak plantar pressure, and contact 
area between foot and plate, 
Smith and his colleagues were 
able to complete the puzzle of the 
foot problems caused by diabetes 
II        I 
i si 
and to understand the major risk 
factors potentially leading to 
amputation. 
Now, with the assistance of 
Barna Szabo, professor of mechani- 
cal engineering and aerospace, the 
research team is building a three- 
dimensional model of a foot with 
the typical features of a person 
suffering from DPN. "Our goal," 
explains Smith, "is to predict the 
characteristics of the orthotic 
device so that the first fit is the 
best fit. If we are successful, the 
recurrence rate of ulcers in a 
patient's foot will drop, new ulcers 
will not form, and patients will 
be spared amputation." 
Three-dimensional modeling 
uses data collected through spiral 
CT from actual patients and a 
complex theoretical mathematics 
technique called finite element 
analysis, which was originally used 
in the aerospace industry and now 
CT Loading Device. A pressure sensor is attached to the 




Some patients with foot ulcers wear specially 
fitted shoes equipped with an insert that 
alleviates pressure on the affected area. 
STATISTICS 
• 18.2 million (6.3%) 
Americans have diabetes. 
• 60% to 70% of people with 
diabetes have mild to severe 
forms of nervous system 
damage, including impaired 
sensation in the feet. 
• Severe forms of diabetic 
nerve disease are a major 
contributing cause of lower- 
extremity amputations. 
• 1 in 4 people with diabetes 
will develop a foot ulcer in 
their lifetime. 
• In the St. Louis metro area, 
5.4% of the population has 
diabetes. 
• In a 2003 survey of diabetic 
patients in the St. Louis-area, 
14% reported having sores or 
irritations on their feet that 
took more than four weeks 
to heal. 
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American Diabetes Association 
(www.diabetes.org) 
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Shoe Doesn't Fit 
is applied in every engineering field 
from industrial design to biomed- 
ical engineering. Working with CT 
images and data collected by MIR 
researchers, Szabo's team con- 
structed a model of the bones, 
cartilage, tissue, and tendons of a 
diabetic patient's foot. Using finite 
element analysis the team solved 
a system of nonlinear equations 
representing the deformation of 
the foot under load. The procedure 
requires the construction of a mesh 
of tetrahedral shapes (elements) 
describing the topology of each 
object. A tetrahedral is a polyhe- 
dron composed of four triangular 
faces; one of the MIR models used 
78,112 tetrahedrons to create the 
3-D foot model. 
Smith and the team are still 
refining this complex model. Once 
tested and validated, it could use 
patient-specific data to reflect that 
patient's bone structure and tissue 
properties. Initially Smith expects 
to obtain these details via CT scan 
but eventually hopes to employ a 
less expensive method such as 
X ray. Combined with the patient's 
weight, the model then could "try 
on" different orthotics and take a 
virtual walk. Simulating pressure 
from standing, pushing off, and 
walking, the model will show 
whether the device distributes 
pressure away from areas at risk 
for ulceration. By adjusting the 
type or thickness of the virtual 
orthotic's material, or its placement 
or shape, researchers can find the 
best orthotic design quickly and 
with minimal modification. One 
day, if all of the pieces come 
together, treating foot problems 
caused by diabetes will be just a 
walk in the park. E333 
3D image of foot and angled tendon. 
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/THE BRITTLE BONE DISEASE 
- THE DUCHESS OF CORNWALL, PRESIDENT OF 
GREAT BRITIAN'S NATIONAL OSTEOPOROSIS SOCIETY 
t's no accident that people around 
the world tend to be preoccupied with 
bones. Among the most devastating effects 
of the postmenopausal retreat of estrogen is 
the loss of bone density. "Peak bone mass occurs 
at about age thirty. Bone mass falls off slowly, but in 
the five years after menopause women lose bone mass 
more rapidly," says Keith Fischer, MD, an associate 
professor of radiology and a nuclear medicine physi- 
cian at Mallinckrodt Institute of Radiology (MIR). He 
uses Dual-Energy 
X-ray Absorptiometry 
to diagnose bone loss 
in his patients. DEXA, 
as it is sometimes 
called, is the established standard for measuring bone 
mineral density and tracking bone loss. It is used most 
commonly to diagnose osteoporosis, a condition in 
which a gradual loss of calcium causes the bones to 
become thinner, more fragile, and more likely to break. 
TOi0 
is not an inevitable part #aging: it is preventable. So it is vital that all of 
us, of all ages, starHaking care of our bones now, before it is too late." 
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"Ideally, a baseline bone 
density study is performed on 
a woman when she is peri- 
menopausal and first starts 
to experience menopausal symp- 
toms. That way, if she is already 
osteopenic, her physician can 
initiate treatment," says Fischer. 
Osteopenia is a mid-point 
value of bone density, between 
the normal range and the range 
designated as osteoporosis. 
Fischer says that men also can 
develop osteoporosis, but they 
seem to lag behind women by 
10 years. Men over 70, especially 
if they have a high risk of 
fractures, should have bone 
density testing. 
How DEXA Works 
According to Fischer, DEXA 
measures the amount of calcium 
phosphate absorbing X rays. 
Bone mineral loss accelerates 
after menopause and affects the 
trabecular bone that forms the 
body's internal supports. The 
vertebrae are made up of 75% 
trabecular bone and the hips are 
50%, so the spine should be the 
more sensitive structure for 
first detecting osteoporosis. 
However, in the older 
patient, other factors 
complicate the results. 
There are calcium 
deposits in plaque in 
the aorta that runs 
through the same 
area and in the facet 
joints between the 
vertebrae where 
osteoarthritis 
is more pro- 
nounced. This 
calcium can be 
measured as bone 
mineral, thus falsely 
elevating the measured 
bone mineral density. 
Figure A (below): A healthy bone 
includes protein, calcium, blood 
vessels, and bone marrow that fill 
in the interior spaces. 
Figure B (below): An osteoporotic bone 
has large "holes," making it fragile and 
more likely to break. 
Keith Fischer, MD 
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DEXA scans of an osteoporotic bone (top) 
and a healthy bone (bottom). 
HOBGC 
The DEXA scanner (below). 
"DEXA doesn't differentiate 
between sources of calcium. It 
counts them all. That's why we 
also study the hip because it 
doesn't have those confounding 
characteristics," says Fischer. 
"The patient is defined as being 
osteoporotic if either of those 
measurements is more than two 
point five standard deviations, or 
SD, below the peak normal bone 
mineral density." 
DEXA works by focusing an 
X-ray beam on the bone and 
measuring how much of the beam 
penetrates the bone. More min- 
eral present in the bone equates 
to less penetration of the X-ray 
beam. Different scores have been 
developed to describe various 
levels of bone loss by comparing 
them to established standards. 
Two scores are calculated and 
communicated in a report to the 
referring physician. The "Z- 
score" is a number repre- 
senting the amount of 
bone the patient has, 
as compared to other 
people of like age 
and sex. The 
"T-score" com- 
pares the amount 
of bone the 
person has, as 
compared to a 
young adult of 
the same sex at peak bone mass. 
If either the hip or the spine 
has a T-score of 2.5 SD below 
peak bone mass, the diagnosis 
is osteoporosis. 
"However, even before a 
patient develops osteoporosis, 
they have lost some bone mass," 
says Fischer. According to 
Fischer, patients whose read- 
ings are 1.0 to 2.5 SD below 
peak are designated as having 
osteopenia, or low bone 
density. If a patient already 
is osteopenic, therapy may 
be appropriate to head off 
osteoporosis. 
Low DEXA scores indicate 
the need for treatment to pre- 
vent fractures and subsequent 
disability. "At Mallinckrodt 
Institute, we are interested in 
the central structures such as 
the spine and hips—bones 
that suffer the ravages of 
osteoporosis. There are three 
hundred thousand hip fractures 
a year in the United States and 
even more vertebral fractures," 
says Fischer. 
Other bones bear the brunt 
of mineral loss as well. Accord- 
ing to Fischer, the distal parts of 
the long bones in the arms lose 
bone mass. When people fall, 
they instinctively extend their 
arms to break the fall; the wrist 
• 
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:es the full impact of the 
ody's weight and breaks, result- 
g in approximately 250,000 
rist fractures annually. 
'Part of a physician's evalua- 
on of fracture risk has to include, 
in addition to bone mineral 
measurements, extrinsic risk fac- 
tors, such as the patient's balance 
and safety risks in the home for 
patients with osteoporosis. Throw 
rugs, unlighted stairways, and 
uneven floors must be factored 
into fracture risk. Also important 
to consider are the intrinsic risk 
factors, like calcium and vitamin 
D intake, medications that could 
contribute to bone loss, and 
a patient's overall nutritional 
status—considerations that 
make people more likely to suffer 
a fracture," says Fischer. 
bones with aches." 
-WILLIAM SHAKESPEARE 
Other uses for DEXA 
DEXA devices also can image 
the whole spine, measure the 
height of the vertebrae, and over 
time track a patient's bone density 
loss and detect early vertebral frac- 
tures. "It's called high-definition, 
instant vertebral assessment," says 
Fischer. "By comparing sequential 
images of the spine, we can deter- 
mine if there has been a vertebral 
fracture. Based on a recent study, 
patients who have had a vertebral 
fracture have a three-fold to 
eleven-fold greater risk of having 
another fracture." This vertebral 
height measurement can be done 
at the same time as conventional 
bone density testing to add more 
CASE STUDIES 
The typical candidate for osteoporosis is a post- 
menopausal woman with one or more risk factors. 
DEXA is utilized both to detect bone mineral loss and to 
follow patients to assess the effectiveness of therapeutic 
interventions. The following cases are illustrative. 
Case A 
A 63-year-old postmenopausal woman presents for a 
follow-up examination. A spine DEXA detected osteo- 
porosis at age 61. She was post total hysterectomy 
at age 38. She was begun on therapy with 
Vitamin D and bisphosphonates. Her bone 
mineral density, which was 0.746 gm/cm2 
at age 61, is now 0.767 gm/cm2. 
Although this is an increase, it is not 
considered statistically significant; ie, the 
increase is within the variability of the test and 
it is uncertain whether it is a real increase. 
She remains in the osteoporotic range of spine bone 
mineral density and needs surveillance bone mineral 
measurements yearly. 
Case B 
A 57-year-old woman with breast cancer presents 
five years after osteopenia of the spine was detected 
by her initial DEXA performed when she was peri- 
menopausal. She was started on calcium and Vitamin 
D supplementation, but a follow-up study of the spine 
at age 56 showed mild decrease in bone density. 
Despite the initiation of bisphosphonate medical ther- 
apy, she continues to lose bone mineral density and 
now measures in the osteoporotic range. She is tak- 
ing Aromasin® (exemestane tablets) for treatment of 
her breast cancer—a further risk factor for bone 
mineral loss. Referral for more intensive monitoring 
of her calcium metabolism and perhaps introduction 
of a structured exercise program is warranted. 
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information to the assessment 
of the need for pharmacologic 
intervention. 
DEXA devices can be used to 
measure body fat with whole-body 
scans as a part of research proto- 
cols. A full-body scan measures 
body composition, including per- 
centage of body fat and lean body 
mass in addition to determining 
bone mineral density of all bones. 
DEXA tends to be more accurate 
for body-fat analysis than is bio- 
electrical impedance analysis (BIA) 
but less accurate than is water dis- 
placement, the standard criterion 
for body-composition analysis. 
DEXA bone density referrals 
The referring physician should 
fax an order to the nuclear medi- 
cine physician or give an order to 
the patient to take to the exam. 
Bone density examinations at 
Mallinckrodt Institute can be 
scheduled by calling 314-362-7111. 
Referring physicians who wish to 
confer with a nuclear medicine 
physician can call 314-454-7997. EH 
HELPFUL WEB SITES 
• National Institutes of Health Osteoporosis and 
Related Bone Disease—National Resource Center: 
www.osteo.org 
• National Osteoporosis Foundation: 
www.nof.org 
• Radiological Society of North America: 
www.radiologyinfo.org/content/dexa.htm 
OSTEOPOROSIS RISK FACTORS 
FOR MEN AND WOMEN 
Indicates need for bone density testing 
• Diagnosed with insulin-dependent 
diabetes, liver disease, kidney disease, 
or hyperthyroidism 
• Family history of osteoporosis 
• Asian or white 
• Advanced age 
• High bone turnover, which shows up as 
excessive collagen in the urine 
• Past vertebral fractures or fracture from 
mild trauma 
• Use of certain drugs that cause bone 
loss, such as some barbiturates, high-dose 
thyroid replacement drugs, anticonvulsants, 
or steroids 
• Cigarette smoking 
• Excessive alcohol use 
• Poor nutrition 
• Low calcium intake/vitamin D deficiency 
• Inactive lifestyle 
Additional risk factors for men 
• Thin or small build 
• Anti-testosterone drug treatment for 
prostate cancer 
Additional risk factors for women 
•Weight under 125 pounds 
•Height over 57" 
• Small-boned 
• Menopausal and not on hormone 
replacement therapy 
18 
MALLINCKRODT INSTITUTE OFRADIOLOGi 
ARK    YOUR    CALENDAR. 
RSNA2005 
Connecting for Lifelong Learning 
Bi i 
m 
91ST SCIENTIFIC ASSEMBLY AND ANNUAL MEETIN 
NOVEMBER 27 - DECEMBER 2, 2005 
MCCORMICK PLACE • CHICAGO 





In this section, the names of employees who are full-time 
faculty or staff or who have an appointment in the 
Department of Radiology or Department of Radiation 
Oncology are highlighted in boldface type. 
PROMOTIONS 
Carmen Dence, MS, 
research scientist of 
radiology, was promoted 
to research associate profes- 
sor of radiology, Division of 
Radiological Sciences, 
Department of Radiology. 
Issam El Naqa, PhD, 
research associate, was 
promoted to research 
instructor in radiation 
oncology, Division of Radia- 
tion Physics, Department of 
Radiation Oncology. 
Jacqueline Esthappan, 
PhD, instructor in radiation 
oncology, was promoted to 
assistant professor of radia- 
tion oncology, Division of 
Radiation Physics, Depart- 
ment of Radiation Oncology. 
Pilar Herrero, MS, research 
scientist of radiology, was pro- 
moted to research associate 
professor of radiology, Divi- 
sion of Radiological Sciences, 
Department of Radiology. 
Eric Klein, MS, associate 
professor of radiation 
oncology, was promoted 
to professor of radiation 
oncology, Division of 
Radiation Physics, Depart- 
ment of Radiation Oncology. 
Robert McKinstry, MD, 
PhD, assistant professor 
of radiology, was promoted 
to associate professor 
of radiology, Division of 
Diagnostic Radiology, 
Department of Radiology. 
Eduardo Moros, PhD, 
associate professor of radia- 
tion oncology, was promoted 
to professor of radiation 
oncology, Division of Radia- 
tion Physics, Department of 
Radiation Oncology. 
Abraham Snyder, MD, 
PhD, research scientist of 
radiology, was promoted to 
research associate professor 
of radiology, Division of 
Radiological Sciences, 
Department of Radiology. 
Suresh Vedantham, MD, 
assistant professor of 
radiology, was promoted 
to associate professor of 
radiology, Division of 
Diagnostic Radiology, 
Department of Radiology. 
Sally Wagner-Schwarz, 
RPh, MS. research scientist 
of radiology, was promoted 
to research associate 
professor of radiology, 
Division of Radiological 
Sciences, Department of 
Radiology. 
Senturia Lecture 
On February 21, Robert Hattery, MD, executive director of The American Board of 
Radiology, presented the Eleventh Annual Hyman R. Senturia Lecture. He spoke on 
"The paradigm shift from lifetime to 10-year time-limited certificates: the ABR 
Maintenance of Certification Plan." 
Hattery (right) received a commemorative plaque from Gilbert lost, MD, chairman of the Department of Radiology 
and director of Mallinckrodt Institute. 
);
     NEW FACULTY 
Wilson Edwards, PhD, 
research instructor in radiol- 
ogy, Division of Radiological 
Sciences, Department of 
Radiology. 
Lakshmi Santanam, PhD, 
instructor in radiation 
oncology, Department 
of Radiation Oncology. 
JOINT 
APPOINTMENT 
Denise Head, PhD, assistant 
professor of psychology, was 
appointed assistant professor 
of radiology, Division of 
Radiological Sciences, 
Department of Radiology. 
Yoram Rudy, PhD, professor 
of biomedical engineering, 
was appointed research pro- 
fessor of radiology, Division 
of Radiological Sciences, 
Department of Radiology. 
GRANTS 
Jason Lewis, PhD, assis- 
tant professor of radiology, 
as principal investigator, 
received a one-year, $249,000 
grant from the National 
Institutes of Health for his 
research on "Beta imager 
2000Z digital imaging system." 
Wen Ping Li, PhD, research 
instructor of radiology, as 
principal investigator, 
received a Molecular Imaging 
Center Pilot Research Project 
grant of $20,000 for research 
on "PET imaging of pancre- 
atic cancer via EGF receptor." 
Buck Rogers, PhD, assis- 
tant professor of radiation 
oncology and of radiology, 
received a $1.2 million grant 
from the National Institutes 
of Health for work on 
"Somatostatin receptor 
based PET imaging of gene 
transfer." Coinvestigators 
for the four-year grant are 
Nobuo Horikoshi, PhD, 
assistant professor of radia- 
tion oncology, and Gregory 
Adams, PhD, Fox Chase 
Cancer Center. Collabora- 
tors for the project include 
Carolyn Anderson, PhD, 
associate professor of radiol- 
ogy; David Piwnica-Worms, 
MD, PhD, professor of radi- 
ology, and Michael Welch, 
PhD, professor of radiology. 
Sheng-Kwei Song, PhD, 
assistant professor of radiol- 
ogy, as principal investigator, 
received a $925,000 grant 
from the National Institutes 
of Health/National Institute 
of Neurological Disorders 
and Stroke for research on 
"Evaluation of spinal cord 
white matter injury using 
DTI." Coinvestigators for the 
four-year grant are Anne 
Cross, MD, Department of 
Neurology; John Russell, 
PhD, Department of Molecular 
Biology and Pharmacology; 
Philip Bayly, PhD, Department 
of Mechanical Engineering 
and Aerospace; and Robert 
Schmidt, MD, PhD, Depart- 
ment of Pathology and 
Immunology. 
Jie Zheng, PhD, assistant 
professor of radiology, as 
principal investigator, 
received a $1.5 million grant 
from the National Institutes 
of Health/National Heart, 
Lung, and Blood Institute for 
work on "Quantification of 
regional myocardial oxygena- 
tion by MRI." Coinvestigators 
for the four-year grant are 
Robert Gropler, MD, pro- 
fessor of radiology; Joseph 
Deasy, PhD, associate pro- 
fessor of radiation oncology; 
and Pamela Woodard, MD, 
assistant professor of 
radiology; and Michael 
Jerosch-Herold, PhD, 




Samuel Achilefu, PhD, 
associate professor of radiol- 
ogy, was appointed to a 
three-year term as a member 
of the Microscopic Imaging 
Study Section, Center for 
Scientific Review, United 
States Department of Health 
and Human Services, 
National Institutes of Health. 
Jeffrey Bradley, MD, assis- 
tant professor of radiation 
oncology, was elected to a 
three-year term as member- 
at-large of the Executive 
Committee of the American 
College of Radiology's 
(ACR's) Radiation Therapy 
Oncology Group. He also 
was elected as a member of 
the ACR's Lung Cancer 
Expert Panel (appropriate- 
ness criteria). 
Craig Glaiberman, MD, 
instructor in radiology, was 
appointed to the Profes- 
sional Education Committee 
of the Society of Interven- 
tional Radiology. 
Sean Higginson, MD, 
third-year diagnostic radiol- 
ogy resident, is the first 
resident physician to be 
appointed to the Board of 
Directors for RADPAC, the 
political action committee 
of the American College of 
Radiology Association. 
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Eric Klein, MS, professor 
of radiation oncology, was 
appointed as chair of the 
American Association 
of Physicists in Medicine 
Subcommittee on 
Quality Assurance for 
Radiation Therapy. 
Jason Lewis, PhD, assis- 
tant professor of radiology, 
was elected to a two-year 
term as treasurer of the 
Radiopharmaceutical Science 
Council of The Society of 
Nuclear Medicine. 
Robert McKinstry, MD, 
PhD, associate professor of 
radiology, was appointed to 
the Trans-National Institutes 
of Health Panel on Incidental 
Findings: Detection and Dis- 
closure of Incidental Findings 
in Neuroimaging Research. 
He was appointed to the 
External Advisory Committee 
of the Comprehensive Sickle 
Cell Center, St. Jude Chil- 
dren's Research Hospital, 
Memphis, Tennessee. 
JeffMichalski, MD, 
associate professor of 
radiation oncology, was 
appointed to the Board of 
Directors of the Missouri 
Radiological Society. 
Pamela Woodard, MD, 
assistant professor of 
radiology, was appointed 
to a three-year term on the 
Scientific Program Commit- 
tee of the American Heart 
Association and as chair of 
the association's Program 
Committee for the Cardio- 
vascular Radiology and 
Intervention Council. 
HONORS/AWARDS 
Louis Gilula, MD, professor 
of radiology and of surgery, 
received the 2005 Outstand- 
ing Presentation Award 
for "Complications of 
fluoroscopically guided 
extraforaminal cervical nerve 
blocks: an analysis of 1,036 
injections" at the 37Ul Annual 
Diagnostic Course in Davos 
Musculoskeletal Diseases, 
Davos, Switzerland, April 2- 
8.   As visiting professor, he 
was a member of the Board 
Review on Musculoskeletal 
Radiology, Oregon Health 
and Science University, Port- 
land, April 22-25. 
LECTURES 
Carolyn Anderson, PhD, 
associate professor of radiol- 
ogy, presented "Chemistry, 
imaging and therapy 
application of copper-64 
radiopharmaceuticals" to 
the Department of Chemistry, 
Florida State University, Tal- 
lahassee, February 24. She 
spoke on "Molecular imaging 
of cancer with copper-64 
radiopharmaceuticals" at 
Florida Atlantic University, 
Boca Raton, March 25. 
Jeffrey Brown, MD, profes- 
sor of radiology, presented 
"MR contrast agents" at Van- 
derbilt University, Nashville, 
Tennessee, February 15. He 
spoke on "MR imaging of the 
indeterminate renal mass" 
at Radiology Grand Rounds: 
MRI of Cholangiocarcinoma 
and Gallbladder Cancer, 
Wake Forest University, 
Winston-Salem, North 
Carolina, March 16. 
Colin Derdeyn, MD, associ- 
ate professor of radiology 
and of neurology and neuro- 
logical surgery, presented 
"Subarachnoid hemorrhage: 
clip versus coil" and "Neu- 
rointerventional procedures 
for the practicing intensivist" 
at the 34u' Critical Care 
Congress, Society of Critical 
Care Medicine, Phoenix, 
Arizona, January 17. He spoke 
on "Overview of cerebral 
hemodynamics" at the 5th 
Annual International Meeting 
on Cerebral Revascularization, 
St. Louis, Missouri, January 
20. He spoke on "Ongoing 
carotid stent trials" and 
"Selection of patients for 
cerebral revascularization: 
the role of hemodynamic 
assessment" at the 8"' Annual 
Joint Meeting of the American 
Association of Neurological 
Surgeons/Congress of 
Neurological Surgeons Joint 
Section on Cerebrovascular 
Disease and American Soci- 
ety of fnterventional and 
Therapeutic Neuroradiology, 
New Orleans, Louisiana, 
February 3 and 4. Derdeyn 
presented "Thrombolytic 
therapy for acute stroke" 
at the 3011' Annual Interna- 
tional Stroke Conference, 
New Orleans, Louisiana, 
February 4. He spoke on 
"Clip versus coil for aneurysm 
debate: pro coils" at the 
NeuroCritical Care Society 
Annual Meeting, Phoenix, 
Arizona, February 25. 
Louis Gilula, MD, professor 
of radiology and of surgery, 
spoke on "Complications in 
1036 cervical nerve blocks" 
at the American Society of 
Spine Radiology 2005 Annual 
Symposium, San Juan, 
Puerto Rico, February 27. 
He presented "Wrist imaging 
entities to know that often 
are not" at Balgrist Hospital, 
Zurich, Switzerland, March 
5. He presented "Wrist and 
hand" at the 37th Annual 
Diagnostic Course in Davos 
Musculoskeletal Diseases, 
Davos, Switzerland, April 2-8. 
Perry Grigsby, MD, profes 
sor of radiation oncology 
and of radiology, spoke on 
"Radiation therapy for thyroid 
cancer" at the Greater St. Lords 
Society of Radiologists meet 
ing, St. Louis, Missouri, 
February 15. He presented 
"Adjuvant treatment of thyroi< I 
cancer" at the 13lh Annual 
Refresher Course and 
Update in General Surgery, 
Washington University in 
St. Louis, Missouri, 
February 24. 
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Jay Heiken, MD, professor 
jf radiology, spoke on "CT 
evaluation of small bowel 
jbstruction" and "CT of the 
abdominal aorta: aneurysm 
rupture and post-operative 
complications" at Indiana 
University, Indianapolis, 
January 12. He presented 
"Contrast administration and 
scan timing for MDCT: single 
to 4, 8, and 16 row" and 
"CT evaluation of suspected 
abdominal aortic rupture" 
at Practical Radiology at 
Whistler, sponsored by the 
University of British Columbia, 
Whistler, February 6-11. He 
presented "Scan and contrast 
administration principles of 
MDCT" at the MDCT Imaging: 
New Challenges for Scan 
and Contrast Optimization 
Symposium, European 
Congress of Radiology, 
Vienna, Austria, March 4-8. 
He spoke on "Contrast 
administration and scan 
timing for multidetector 
CT," "CT evaluation of small 
bowel obstruction," and 
"Tough liver cases: take the 
challenge!" at the Intema- 
ional London Course in CT, 
V1RI, and PET, Auchterarder, 
Perthshire, Scotland, March 
20-24. He presented "Con- 
trast optimization in MDCT," 
"Liver imaging with MDCT," 
and "Pancreatic MDCT" at 
MDCT: A Practical Approach, 
sponsored by the Society of 
Computed Body Tomogra- 
phy and Magnetic Resonance, 
Scottsdale, Arizona, April 2, 
and Dallas, Texas, April 16. 
William McAlister, MD, 
professor of radiology, 
presented a workshop on 
"Skeletal dysplasia" at the 48d' 
Annual Meeting of the Society 
for Pediatric Radiology, New 
Orleans, Louisiana, May 5. 
Jeff Michalski, MD, associ- 
ate professor of radiation 
oncology, spoke on "The role 
of external RT, brachytherapy, 
adjuvant/neoadjuvant hor- 
monal therapy for localized 
disease and following RP" at 
the Israel Society for Clinical 
Richard Laforest, PhD, 
assistant professor of radiol- 
ogy, spoke on "Measurements 
of input functions in rodents: 
challenges and solutions" at 
the Third La Jolla Conference: 
The Magic Bullet, a Century 
Later, La Jolla, California, 
February 26. 
Biello Lecture 
Daniel Silverman, MD, PhD, associate professor of molecular and medical pharmacol- 
ogy, is head of the neuronuclear section and associate director of the Alzheimer's Dis- 
ease Center Imaging Core at the David Geffen School of Medicine at the University of 
California, Los Angeles. As guest speaker for the Nineteenth Annual Daniel R. Biello 
Memorial Lecture on March 14, Silverman spoke on "FDG-PET in the evaluation of mild 
cognitive impairment, Alzheimer's disease, and related disorders." 
Shown with Silverman (left) is Barry Siegel, MD, chief of the Institute's Division of Nuclear Medicine and coordinator of 
the Biello Lecture. 
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Continued from page 23 
Oncology and Radiation 
Therapy Conference, Eilat, 
Israel, January 12-14. He 
presented "Radiation therapy 
for prostate cancer, from 3D 
CRT to IMRT" at the 15"' 
Annual Meeting of the 
American College of Radia- 
tion Oncology, Las Vegas, 
Nevada, February 24-27. 
Jeffrey Neil, MD, PhD, 
professor of neurology, of 
pediatrics, and of radiology, 
presented "Survey and 
current status of research 
on biophysical issues in 
diffusion MRI of brain. 
Progress since the last 
workshop in St. Malo" at the 
International Society for MR 
in Medicine Workshop on 
Methods for Quantitative 
Diffusion MRI of the Human 
Brain, Lake Louise, Alberta, 
Canada, March 13-16. 
Fred Prior, PhD, research 
associate professor of 
radiology, spoke on "Digital 
modalities, study acquisition, 
distribution and storage 
requirements" and "Storage 
hardware and infrastructure" 
at the PACS 2005 Confer- 
ence, San Antonio, Texas, 
March 9-12. 
David Rubin, MD, associate 
professor of radiology, 
spoke on "Knee" at the 37th 
Annual Diagnostic Course 
in Davos Musculoskeletal 
Diseases, Davos, Switzerland, 
April 2-8. 
Barry Siegel, MD, professor 
of radiology and of medicine, 
presented "Breast cancer: 
solutions" and "Gynecologi- 
cal malignancies: solutions" 
at the PET/CT and SPECT/CT 
Imaging of Cancer for 
Radiologists and Nuclear 
Physicians, sponsored by 
Johns Hopkins University, 
Baltimore, Maryland, March 
18 and 19. He spoke on "PET 
and PET/CT in lung cancer" 
and "PET in gynecologic 
cancer" at Imaging 2005: Hot 
Topics and Current Issues, 
sponsored by The New York 
Roentgen Society, New York 
City, New York, March 30- 
April 2. He presented "PET 
and PET/CT in lung cancer 
and breast cancer" at Radiol- 
ogy Grand Rounds as well as 
"PET artifacts and variants" 
and "Endocrine nuclear 
medicine imaging" at Eastern 
Virginia Medical School, 
Norfolk, Virginia, April 18. 
Siegel presented "Applica- 
tions of PET and PET/CT in 
clinical oncology" at Nuclear 
Medicine Grand Rounds, 
State University of New York 
at Buffalo, April 27. 
Marilyn Siegel, MD, 
professor of radiology and of 
pediatrics, spoke on "CT/MRI 
of focal hepatic masses in 
children" and "CT of common 
thoracic lesions in children" 
at Oregon Health and 
Science University, Portland, 
February 3. She presented 
"Pediatric CT angiography," 
"CT angiography of adult 
mediastinal arterial anom- 
alies," and "CT angiography 
of adult mediastinal venous 
anomalies" at the Advanced 
Topics in CT Scanning: CT 
Angiography, 3D Imaging, 
Virtual Imaging Course, 
sponsored by Johns Hopkins 
University, Los Angeles, 
California, April 1-3 and Bal- 
timore, Maryland, April 7-9. 
She spoke on "MDCT of 
adult mediastinal vascular 
anomalies," "CT/MR of pedi- 
atric mediastinal lesions," 
and "CT of pediatric congen- 
ital lung anomalies" at North 
Shore University Hospital, 
Manhasset, New York, April 13. 
Joseph Simpson, MD, 
PhD, professor of radiation 
oncology, presented "Image 
guided radiation therapy" 
at the Carle Clinic, Urbana, 
Illinois, January 29. 
Franz Wippold, MD, pro- 
fessor of radiology, spoke on 
"Lumbar spine: the herniated 
disk" at the 2005 Annual Meet- 
ing of the American Academy 
of Orthopaedic Surgeons, 
Washington, DC, February 24. 
SYMPOSIA 
In this section ofFYI, only 
those faculty and staff 
who have Department of 
Radiology or Department 
of Radiation Oncology 
appointments are listed. 
THE SOCIETY OF 
GASTROINTESTINAL 
RADIOLOGISTS/ 




San Antonio, Texas 
February 27-March 4, 2005 
Dennis Balfe, MD, program 
director. 
Jay Heiken, MD, moderator, 
Plenary Session: Abdominal 
Emergencies. 
Christine Menias, MD, 
panelist, Unknown Case. 
WORKSHOPS 
Jay Heiken, MD, "Small 
bowel obstruction." 
Elizabeth McFarland, MD, 
"CT colonography: technique 
and avoiding pitfalls." 
Christine Menias, MD, 
"CTofRLQpain." 
PLENARY SESSION 
Sharlene Teefey, MD, 
"Complicated cholecystitis." 
MALLINCKRODT INSTITUTE OF RADIOLOi 
AMERICAN COLLEGE OF 
CARDIOLOGY 
54th Annual Scientific 
Session Exposition 
Orlando, Florida 
March 6-9, 2005 
Robert Gropler, MD, 
cochair, Advances in 
SPECT/PET for Risk 
Stratification; moderator, 
Read with the Experts... 
Imaging Perfusion and 
Metabolism with PET, 
SPECT, and PET/CT. 
Madelyn Stazzone, MD; 
Pamela Woodard, MD; 
Michael Pasque, MD; 
Glenn Foster, RT; Philip 
Ludbrook, MD, "Myocardial 
scarring and fibrosis in the 
failing single ventricle after 
Fontan operation: a new 
insight by MRI studies." 
Victor Davila-Roman, MD, 
"Cardiac resynchronization 
therapy improves left ven- 
tricular diastolic function in 
nonischemic heart failure." 
SOCIETY OF COMPUTED 
BODY TOMOGRAPHY AND 
MAGNETIC RESONANCE 
28th Annual Course 
South Beach, Florida 
March 21-25, 2005 
REFRESHER COURSE 
Marilyn Siegel, MD, "Medi- 
astinal masses and congenital 
lung lesions in children." 
Purdy Lecture 
FOCUS SESSIONS 
Kyongtae Bae, MD, PhD, 
"Principles and practice of 
contrast material delivery for 
MDCT'and "PET/CT basic 
principles." 
Stuart Sagel, MD, "CT of 
thoracic vascular masses." 
CARDIOVASCULAR IMAGING 
SESSION 2 
Marilyn Siegel, MD, 
"MDCT of adult congenital 
heart disease" 
SPOTLIGHT ON PROTOCOLS: 
PERIPHERAL MRA 
Stuart Sagel, MD, "CT 
angiography for pulmonary 
embolism: technique 
interpretation and role." 
The Department of Radiation Oncology sponsored the Third Annual James A. 
Purdy Physics Lecture on April 22. Clifton Ling, PhD, chairman of the Department 
of Medical Physics at Memorial Sloan-Kettering Cancer Center, presented the 
keynote address: "p02 - C135 - D3 and back." 
(Left to right): Simon Powell, MD, PhD, chairman of the Department of Radiation Ontology; Ling; and James Purdy, PhD. 
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New Orleans, Louisiana 
March 31-April 5, 2005 
Daniel Brown, MD, pan- 
elist, Lessons Learned: Chest 
Interventions; comoderator, 
Visceral Arteries/Solid Organ 
Intervention; coordinator, 
Gastrointestinal IR: Tech- 
niques and Management. 
Michael Darcy, MD, pan- 
elist, Case Based Review: 
Vascular Interventions II; 
comoderator, Portal 
Hypertension. 
David Hovsepian, MD, 
comoderator, Fibroid 
Embolization. 
Thomas Vesely, MD, co- 
ordinator, Venous Access. 
WORKSHOPS 
Daniel Brown, MD, 
"Regional cancer therapy," 
"The IR approach." 
Craig Glaiberman, MD, 
"Venous access," "Gastroin- 
testinal interventions." 
Suresh Vedantham, MD, 
"Thrombolytic therapy for 
venous disease." 
Thomas Vesely, MD, 
"Hemodialysis access." 
PLENARY SESSIONS 
Daniel Brown, MD, "What 
the IR needs to know—HCC." 
Michael Darcy, MD, 
"Ambulatory phlebectomy: 
indications and techniques." 
Colin Derdeyn, MD, 
"Stroke management: acute 
stroke imaging." 
Thomas Vesely, MD, 
"Angioplasty: POBA and 
beyond." 
SCIENTIFIC PRESENTATIONS 
David Hovsepian, MD, 
"Comparison of adjunctive 
use of rofecoxib (Vioxx) 
vs. ibuprofen in the manage- 
ment of postoperative pain 
after UFE." 
Suresh Vedantham, MD; 
Gregorio Sicard, MD; 
Brian Rubin, MD; Thomas 
Pilgram, PhD; Thomas 
Vesely, MD; Michael 
Darcy, MD, "Uiofemoral 
DVT: pharmacomechanical 
thrombolysis with early 
stenting versus conventional 
pharmacologic thrombolysis." 
Thomas Vesely, MD, "Mea- 
surement of air flow through 
a valved peelable introducer 
sheath," "Use of stent grafts 
to repair hemodialysis graft 
related pseudoaneurysms." 
SOCIETY FOR THERMAL 
MEDICINE 
2005 Annual Meeting 
Bethesda, Maryland 
April 1-3, 2005 
Eduardo Moros, PhD, 
comoderator,Engineering/ 
Physics Workshop. 
Petr Novak, PhD, recipient, 
Young Investigator Travel 
Award; comoderator, 
Engineering/Physics 
Symposium: Image Guided 
Thermal Therapy, Treatment 
Monitoring, and Tissue 
Assessment. 
Joseph Roti Roti, PhD, mem- 
ber, Organizing Committee. 
William Straube, MS, 
comoderator, Engineering/ 
Physics Symposium: Treat- 
ment Planning, Control, and 
Thermal Modeling. 
PLENARY SESSIONS 
Eduardo Moros, PhD, 
"SURLAS," "Highlights of 
engineering/physics." 
SCIENTIFIC PRESENTATIONS 
Bibianna Cha; Eduardo 
Moros, PhD; William 
Straube, MS; Robert 
Myerson, MD, PhD; Petr 
Novak, PhD, "Final design 
and preliminary testing of a 
Linac-SURLAS-patient trans- 
port for simultaneous ther- 
moradiotherapy." 
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Eduardo Moros, PhD; 
James Alaly; Konstantin 
Zakaryan, PhD; Joseph 
Deasy, PhD; Petr Novak, 
i    PhD, "Integrated thermoradio- 
i    therapy treatment planning 
i    system—a computational 
I    environment for long-term 
i    developments and initial 
results." 
Eduardo Moros, PhD, 
"Basic bio-heat transfer 
considerations and effective 
heating of tumors in 
animal models." 
Robert Myerson, MD, 
PhD, "Simultaneous radia- 
tion therapy and hyperthermia 
in the elective treatment of 
subclinical disease in high 
risk breast carcinoima: a 
phase III comparison of post 
treatment normal tissue 
effects in heated and 
unheated portions of the 
chest wall." 
Petr Novak, PhD; Eduardo 
Moros, PhD; William 
Straube, MS, "The impact 
of ultrasound nonlinear 
propagation on SURLAS 
design and performance." 
Joseph Roti Roti, PhD, 
"Changes in nuclear DNA 
organization and DNA repair 
proteins that lead to 
radiosensitization by 41CC 
hyperthermia." 
William Straube, MS, 
"An in vivo system for the 
determination of the effect 
of temperature on 
backscattered ultrasound." 
Robert VanderWaal, PhD, 
"Heat induced 'masking' of 
protein disulfide isomerase, 
a redox sensitive nuclear 
component of the DNA- 
nuclear matrix anchoring 
complex." 
Mai Xu, MD, PhD, 
"Enhancement of thermal 
radiosensitization by 
Indomethacin and related 
compounds." 
Konstantin Zakaryan, 
PhD; James Alaly; Petr 
Novak, PhD; Joseph Deasy, 
PhD; Eduardo Moros, PhD, 
"Simple acoustic beam model 
for thermoradiotherapy 
implemented in an open 




87th Annual Meeting 
Barcelona, Spain 
April 30-May 4, 2005 
Perry Grigsby, MD, "Func- 
tional imaging, translational 
science, and clinical outcome 
in carcinoma of the cervix"; 
"Advances in GYN malignan- 
cies"; "Assessing tumor 
hypoxia in cervical cancer 
by positron emission tomog- 
raphy with ^Cu-ATSM"; 
"Pre-treatment metabolic 
activity in cervical cancer." 
Lilie Lin, MD, "Sequential 
FDG-PET brachytherapy 
treatment planning in carci- 
noma of the cervix." 
We sadly report the death of John Christian Mason, PhD, who died suddenly on April 24. 
He was 34 years old. Dr. Mason joined the Division of Radiological Sciences in October 2004 
as a postdoctoral research associate in the Institute's Optical Radiology Laboratory. He is 
survived by his wife, Hyeran, and four-year-old daughter Brooke. Donations may be made 
to the Mason Family Trust, Pulasld Bank, 12300 Olive Boulevard, St. Louis, Missouri 63141. 
Send to the attention of Chuck Carpenter, senior vice president. 
Parag Parikh, MD, 
"Inspiration gating reduces 
lung cancer treatment volumes 
and potential irradiation 
treatment toxicities," "The 
use of radiation in the treat- 
ment of Hodgkin's disease." 
In the Winter 2004/2005 
issue of Focal Spot 
magazine, Barry Brunsden 
was inadvertently omit- 
ted from the list of 
Hobbit research team 
members (page 19). 
We regret the error. 
As a research engineer, 
Brunsden is an impor- 
tant part of the Hobbit 
team as well as other 
research conducted in 
the Institute's Electronic 
Radiology Laboratory. 
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Ronald Evens, MD, former 
chairman of the Department 
of Radiology and director of 
Mallinckrodt Institute of 
Radiology (1971-1999), 
retired May 1, 2005, as presi- 
dent of Barnes-Jewish Hospi- 
tal in St. Louis. He maintains 
a senior-level role with BJC 
HealthCareSM, where he will 
lend his experience and 
expertise on special projects. 
Gary Shackelford, MD, 
emeritus professor of 
radiology, retired from 
Mallinckrodt Institute in 
June 2002. But the Shack- 
elf ords (wife Penny was a 
physician in the Depart- 
ment of Pediatrics) are 
working harder than ever 
to restore their rural prop- 
erty in southern Wisconsin 
(Fair Meadows) to its nat- 
ural condition of woods, 
prairies, and wetlands. 
They are the recipients of 
three state and federal 
grants to assist in their 
restoration efforts. 
In 2001, Fair Meadows 
was named Wisconsin's 
Outstanding Tree Farm by 
the American Tree Farm 
System and, in 2003, the 
Shackelfords received the 
Natural Roadside Award 
from the Rock County 
Conservationists, a local 
group that promotes con- 
servation. They also have 
been the recipients of a 
Wildlife Conservation 
Award from the Rock 
County Land Conservation 
Department. 
(left to right) Drs. Gary and Penny Shackelford and Beverlee Sagel. 
Photo courtesy of Stuart Sogel, MD, professor of radiology. 
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RISK OF COLON CANCER? 
SCREENING COLONOSCOPY 
50 YEARS 
^>olorectal cancer is the 
second most common /I 
cause of cancer-related 
deaths in the United 
States.  Ifcolorectal 
cancer is diagnosed    *y 
in its early stages, 
the survival rate     /* 
is 90%. 
Help fight colon 
cancer by volun- 
teering for the 
National Colon 
Cancer Screening at 
Mallinckrodt Institute of 
Radiology at Washington 
University in St. Louis. 
This study is part of a National 
Cancer Institute-funded effort to determine whether computed tomography (CT) 
colonography can provide the necessary information for doctors to diagnose colon 
cancer in its early stages. 
CT colonography, also called virtual colonoscopy, is faster (takes about 20 minutes) 
and less invasive than standard colonoscopy. Eligible study participants will receive a 
CT colonography (free of charge) in addition to your regularly scheduled colonoscopy 
(billed to your insurance carrier or to you). 
Christine Menias, MD, a board-certified radiologist, is the principal investigator 
of the Washington University segment of the study. For more information, call 
Ruth Holdener, RT, at (314) 747-2034. 
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